Drug Trial Radar · NCT04483947
A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients
Last checked: Nov 19, 2026Latest source record: Jan 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Nov 6, 2020
Primary completion
Dec 18, 2023
Study completion Dec 18, 2023
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Jul 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is intended to investigate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD2693, following subcutaneous (SC) administration of multiple ascending doses in participants with Non-alcoholic Steatohepatitis (NASH) with fibrosis Stage 0 to 3 and who are carriers of the patatin-like phospholipase domain-containing 3 (PNPLA3) 148M risk alleles.
Conditions
- Non-alcoholic Steatohepatitis (NASH)
Interventions
AZD2693Drug
Subcutaneous administration of AZD2693 multiple ascending doses in participants with NASH and who are carriers of the PNPLA3 148M risk allele(s).
PlaceboOther
Participants randomised to placebo will receive the corresponding dose volume of solution as participants receiving AZD2693 within the same cohort
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse eventsTime frame: Up to 32 weeks (From Screening to Final Visit)
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Chula Vista, California
Research Site
La Mesa, California
Research Site
Montclair, California
Research Site
San Diego, California
Research Site
Doral, Florida
Research Site
Hialeah, Florida
Research Site
Hialeah, Florida
Research Site
Miami Lakes, Florida
Research Site
Indianapolis, Indiana
Research Site
Morehead City, North Carolina
Research Site
Columbus, Ohio
Research Site
Hershey, Pennsylvania
Research Site
Arlington, Texas
Research Site
Dallas, Texas
Research Site
San Antonio, Texas
Research Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.